INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 456m ago
House PTR55m ago
SEC 13F55m ago
Robinhood Chain55m ago

Results

8,832 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$23K
2,061 sh
Nov 20, 2025Jan 30, 2026
Page 162 of 221
← PrevNext →
traded Nov 20, 2025
+71d
SEC Form 4

Evidence

31
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,702
98 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

31
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
303 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

31
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,268
73 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

30
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$150K
1,395 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$698K
54.1K sh
Jan 9, 2026Jan 30, 2026
traded Jan 9, 2026
+21dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$583K
56.2K sh
Jan 7, 2026Jan 30, 2026
traded Jan 7, 2026
+23dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$526K
38.1K sh
Jan 14, 2026Jan 30, 2026
traded Jan 14, 2026
+16dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$994K
82.3K sh
Jan 8, 2026Jan 30, 2026
traded Jan 8, 2026
+22dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$976K
66.5K sh
Jan 13, 2026Jan 30, 2026
traded Jan 13, 2026
+17dSEC Form 4

Evidence

49
FC
Fleming Allysun CExecutive Vice President
CMACOMERICA INC
Open-market sale
SELL$837K
8,864 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

43
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$629K
677 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

41
TC
Trabuco CarolynDirector
USARUSA Rare Earth, Inc.
Open-market purchase
BUY$29K
1,300 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$676K
728 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

39
Solomon David MDirector, Chairman of the Board and CEO
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$218K
232 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

38
JR
Jeffrey John Ronald Jr.Director
AGXARGAN INC
Open-market sale
SELL$1.80M
5,000 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

36
Solomon David MDirector, Chairman of the Board and CEO
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$38K
40 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

36
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$156K
168 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

36
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$217K
235 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

36
BM
Butler Amy MEVP, NATIONAL SALES
NPBNORTHPOINTE BANCSHARES INC
Open-market sale
SELL$123K
6,800 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
BM
Butler Amy MEVP, NATIONAL SALES
NPBNORTHPOINTE BANCSHARES INC
Open-market sale
SELL$111K
6,365 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$145K
157 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$86K
92 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$79K
85 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$200K
216 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$158K
171 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$179K
193 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$103K
112 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

30
HD
Hahnfeld Jeffrey DEVP-CONTROLLER & CHIEF ACC OFF
WTFCWINTRUST FINANCIAL CORP
Open-market sale
SELL$46K
314 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

66
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$124K
53.6K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

44
SM
Stasiowska Ewa MariaChief Risk Officer
LOBLive Oak Bancshares, Inc.
Open-market purchase
BUY$100K
2,595 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

39
HE
Hutchinson Russell E.Chief Financial Officer
ALLYAlly Financial Inc.
Open-market purchase
BUY$499K
11.6K sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,238 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
730 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,239 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
731 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
WG
Williams GreggDirector, 10% Owner
VANIVivani Medical, Inc.
Open-market purchase
BUY$2.00M
1.35M sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence